Quantcast

Latest Pharmacology Stories

2014-09-16 23:11:20

Expert dermatologist Dr. Mitchel Goldman of Cosmetic Laser Dermatology discusses the importance of only using FDA approved dermal fillers. San Diego, CA (PRWEB) September 16, 2014 A recent article discusses the dangers of an injectable substance used as a dermal filler, “Expression”, which has not been approved for cosmetic use. “Expression” was originally put on the market to be used as an intra-nasal splint following rhinoplasty, and was never approved by the FDA for use as a...

2014-09-16 23:11:15

Texas A&M Veterinary Medicine and Biomedical Sciences student Therese Gavin takes top honors in Diamondback Drugs annual essay contest. Scottsdale, Arizona (PRWEB) September 16, 2014 Recognizing the role of today’s veterinary students in shaping the future of the field, Scottsdale, Arizona’s Diamondback Drugs developed the Max Memorial Essay Competition. This year, the winner of the essay contest is Therese Gavin, a student at Texas A&M’s school of Veterinary Medicine and...

2014-09-16 23:07:50

The CNPR certificate, since its inception of the Fall of 1999, has proven to help entry level applicants understand all of the pharmaceutical industry terms, product knowledge and regulations needed to work as a successful pharmaceutical sales rep. The CNPR program is widely known to help entry level applicants with their knowledge of the industry which then allows them to meet basic pharmaceutical sales job pre-requisites. Washington, DC (PRWEB) September 16, 2014 Building a workforce...

2014-09-16 23:04:40

For the first time, Orange Paper readers will have a detailed snapshot of clinical trials in Ukraine MOSCOW, Russia (PRWEB) September 16, 2014 Synergy Research Group has debuted the Ukraine Orange Paper. The comprehensive report gives the best detail and analysis of the state of clinical trials in Ukraine. Data was pulled from a variety of sources, including Ministry of Health in Ukraine and the FDA, etc. The Ukraine Orange Paper will give readers actionable intelligence on clinical...

2014-09-16 23:03:11

Topical research report “Pediatric Drug Development - Regulatory Challenges and Commercial Opportunities” worked out by CBR Pharma Insights is now available at MarketPublishers.com. London, UK (PRWEB) September 16, 2014 Since the adoption of pediatric legislation, the number of paediatric clinical trials has risen considerably in line with increased investment in R&D for pediatric drugs. In the USA, over 350 product labels include novel paediatric information and more than 130...

2014-09-16 20:27:34

-- PEG-Irinotecan is a novel, long-acting polymer-drug conjugate which inhibits Topo-I associated with solid tumors SHENYANG, China, Sept. 16, 2014 /PRNewswire/ -- 3SBio Inc., ("3SBio") a leading biotechnology company based in China focusing on researching, developing, manufacturing and marketing biopharmaceutical products, announced today that it has entered into an exclusive license agreement with JenKem Technology Co., Ltd ("JenKem") for the development, manufacturing and...

2014-09-16 12:36:52

WINNETKA, Calif., Sept. 16, 2014 /PRNewswire/ -- Green Cures & Botanical Distribution Inc. (OTC Pink: GRCU) ("Green Cures") announced today that Allcbd.com, the newest member of Green Cures' portfolio of websites, is now receiving and processing orders from customers across the United States. Additionally, Green Cures is pleased to announce that Allbotanical.com is now shipping orders internationally. Subsequently, the company announced the immediate availability of South African-...

2014-09-16 12:31:31

SAN DIEGO, Sept. 16, 2014 /PRNewswire/ -- Denovo Biopharma, LLC, today announced that it has acquired enzastaurin, a late-stage oncology drug, from Eli Lilly and Company (NYSE: LLY). Denovo gains all rights to develop, manufacture and commercialize enzastaurin globally, including transfer of all intellectual property and other rights, data, and information. http://photos.prnewswire.com/prnvar/20140820/138306 Lilly developed enzastaurin in a variety of indications, including in...

2014-09-16 12:30:44

SCHAUMBURG, IL, Sept. 16, 2014 /PRNewswire/ - Catamaran Corp. (NASDAQ: CTRX) (TSX: CCT), a leading provider of technology and pharmacy benefit management (PBM) services, announces that Tony Perkins, Investor Relations, will present at the Cantor Fitzgerald Canada 3(rd) Annual Technology Conference in Toronto, Ontario. Catamaran's presentation will take place on Tuesday, September 23, 2014, at 9:30 a.m. ET. About Catamaran Catamaran, the industry's fastest-growing pharmacy...

2014-09-16 12:30:41

Rheumatologists Report that the Vast Majority of RA Patients Who are Candidates for Biologic Treatment Receive a Biologic, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept. 16, 2014 /PRNewswire/ -- Decision Resources Group finds that the percentage of rheumatoid arthritis (RA) patients treated with a biologic agent by rheumatologists has remained relatively constant since 2012 in the major European markets (France, Germany, Italy, Spain and the United Kingdom)....


Latest Pharmacology Reference Libraries

Pharmacophobia
2013-12-24 12:55:45

Pharmacophobia or medication phobia, comes from Greek pharmakon, meaning “drug, medicine” and phobos, meaning “fear”, is the fear of the use of pharmacological treatments. In severe, excessive, and irrational cases, it might be a type of specific phobia. While lack of awareness by patient of adverse drug reactions can have a serious consequence, having a phobia of medications can also have serious detrimental effects on the patient’s health. Medication phobia can also lead to...

Generalized Anxiety Disorder
2013-07-25 15:07:54

Generalized Anxiety Disorder (GAD) is an anxiety disorder with worry about normal, everyday situations such as finance, health and wellbeing in relationships (personal and work related) all lasting longer than six months. Symptoms The symptoms of GAD can include but are not limited to difficulty swallowing, rashes, shortness of breath, fidgeting, headaches, tension, nausea, etc. In order for GAD to be ruled as present, the symptoms and feelings must be experiences for at least six...

European Journal of Medical Chemistry
2012-05-12 22:03:06

The European Journal of Medical Chemistry is a peer-reviewed scientific journal for medical chemistry. It is published by Elsevier. It was established in 1966 under the title Chimica Therapeutica. That name was maintained until 1973. Even after changing to its current name in 1974, the journal was still subtitled Chimica Therapeutica until 1981; from 1982 to 1986 it was subtitled Chimie Therapeutique, indicating its French origin. The Journal publishes studies on all aspects of medicinal...

0_3ff7149ca288229c28bcd855846ea8c7
2009-04-28 16:00:11

Bursera graveolens or Palo Santo is a tree indigenous to South America in Argetina, Paraguay, Boliva and coastal areas of Ecuador. Palo Santo means "holy wood" in English and belongs in the same family as frankincense and myrrh. Although it has been used in homeopathic medicine for years, most recently it is the extraction of essential oils that has put this plant in the spotlight. Limonene, a-Terpineol, Menthofuran and Carvone are a few of the oils derived from this plant. Native...

31_c737ff73aa3c47be364b2a8cce214e0c
2005-07-12 18:32:21

Datura wrightii (a poisonous weed) is sometimes used as a hallucinogen. It is commonly called Sacred Datura. Datura wrightii is classified as a deliriant, or an anticholinergic. In the US it is, however, called Western Jimson Weed.

More Articles (5 articles) »
Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.